U.S., Sept. 17 -- An application to own the trademark for 'S-GLYN' has been filed on May. 10, 2024.
Owner(s):
Samsung Biologics Co., Ltd.; 300, Songdo bio-daero,, , REPUBLIC OF KOREA
Goods and/or Services:
For: Custom manufacture of biopharmaceuticals; processing of biopharmaceutical materials for others; treatment of biopharmaceutical materials; custom manufacture of cell lines for manufacturing biopharmaceuticals; chemical treatment of liquids; processing of medicinal materials; custom manufacture of pharmaceuticals; processing of pharmaceutical preparations; preservation of pharmaceuticals; processing of pharmaceuticals; custom manufacture of specific antibody-binding glycosylation drugs; processing of chemicals.
Class(es): 100, 103...